-+ 0.00%
-+ 0.00%
-+ 0.00%

Axsome Therapeutics's Earnings Outlook

Benzinga·02/20/2026 17:01:33
Listen to the news

Axsome Therapeutics (NASDAQ:AXSM) is preparing to release its quarterly earnings on Monday, 2026-02-23. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Axsome Therapeutics to report an earnings per share (EPS) of $-0.72.

The announcement from Axsome Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Performance in Previous Earnings

In the previous earnings release, the company beat EPS by $0.19, leading to a 0.6% drop in the share price the following trading session.

Here's a look at Axsome Therapeutics's past performance and the resulting price change:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.87 -1.05 -1.35 -0.99
EPS Actual -0.68 -0.47 -0.68 -0.80
Price Change % -1.00 -3.00 -4.00 -1.00

eps graph

Stock Performance

Shares of Axsome Therapeutics were trading at $186.175 as of February 19. Over the last 52-week period, shares are up 40.61%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Axsome Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.